Mosseri Marlio Charles's Form 4/A amendment
AmendedNuvectis Pharma, Inc. (NVCT) · filed Dec 16, 2024
- Accession no.
- 0001104659-24-129009
- Filed
- Dec 16, 2024
- Trade date
- Dec 12-13, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 16, 2024
This filing lists 2 non-derivative transactions. Open-market purchases total $228.9K. It was filed 4 days after the trade.
This amendment replaces 0001104659-24-128688 (filed Dec 16, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Common Stock | PPurchaseAcquired | +32,121 | $4.64 | +$149,041.44 | 2,627,121 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +17,000 | $4.70 | +$79,900 | 2,644,121 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions.